Back to Search
LUIS A GARZA MD-PHD
MD-PHD
Dermatology Physician
NPI: 1427074517Individual
Specialties, Licenses & Credentials
Dermatology PhysicianPrimary
Dermatology
Code: 207N00000X
MD426253(PA)D69136(MD)
Education
PERELMAN SCHOOL OF MED AT THE UNIVERSITY OF PENNSYLVANIA
Class of 2001
Research & Publications (20)
Developmental expression pattern of the cholesterogenic enzyme NSDHL and negative selection of NSDHL-deficient cells in the heterozygous Bpa(1H)/+ mouse.
PMID 19631568·Mol Genet Metab·2009
7-preclinical
Enabled interferon signaling evasion in an immune-competent transgenic mouse model of parainfluenza virus 5 infection.
PMID 17964629·Virology·2008
7-preclinical
Effect of increased pigmentation on the antifibrotic response of human skin to UV-A1 phototherapy.
PMID 18645136·Arch Dermatol·2008
2-rct
Inflammatory markers, angiographic severity of coronary artery disease, and patient outcome.
PMID 17398176·Am J Cardiol·2007
8-other
Single coronary artery with prepulmonic coursing left main coronary artery manifesting as prinzmetal's angina.
PMID 18172528·Tex Heart Inst J·2007
5-case
In vivo stimulation of de novo collagen production caused by cross-linked hyaluronic acid dermal filler injections in photodamaged human skin.
PMID 17309996·Arch Dermatol·2007
2-rct
Clinical characteristics, process of care, and outcomes of Hispanic patients presenting with non-ST-segment elevation acute coronary syndromes: results from Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines (CRUSADE).
PMID 16824839·Am Heart J·2006
4-observational
Coronary artery restenosis: vascular biology and emerging therapeutic strategies.
PMID 16918273·Expert Rev Cardiovasc Ther·2006
6-review
Relation of microalbuminuria and coronary artery disease in patients with and without diabetes mellitus.
PMID 16860009·Am J Cardiol·2006
4-observational
A nonneutralizing anti-HIV Type 1 antibody turns into a broad neutralizing antibody when expressed on the surface of HIV type 1-susceptible cells. II. Inhibition of HIV type 1 captured and transferred by DC-SIGN.
PMID 16989613·AIDS Res Hum Retroviruses·2006
8-other
Inhibition of platelet aggregation with eptifibatide, bivalirudin, and heparin in patients undergoing percutaneous coronary intervention receiving clopidogrel pretreatment (The PharmacoDynamic Evaluation of Angiomax, Clopidogrel with or without INtegrilin [DEACON] study).
PMID 15950569·Am J Cardiol·2005
3-trial
Trends in the care of patients with acute myocardial infarction at a university-affiliated Veterans Affairs Medical Center.
PMID 15821837·J Cardiovasc Pharmacol Ther·2005
8-other
Renin-angiotensin polymorphisms and QTc interval prolongation in end-stage renal disease.
PMID 16105049·Kidney Int·2005
8-other
Pleuropericarditis and pericardial tamponade associated with inflammatory bowel disease.
PMID 16032926·J Ark Med Soc·2005
5-case
Comparative pharmacodynamic evaluation of eptifibatide and tirofiban HCl in patients undergoing percutaneous coronary intervention (the TAM1 Study).
PMID 15135704·Am J Cardiol·2004
3-trial
Comparative pharmacodynamic evaluation of eptifibatide and abciximab in patients with non-ST-segment elevation acute coronary syndromes: the TAM2 study.
PMID 15789173·J Thromb Thrombolysis·2004
3-trial
A nonneutralizing anti-HIV-1 antibody turns into a neutralizing antibody when expressed on the surface of HIV-1-susceptible cells: a new way to fight HIV.
PMID 15383596·J Immunol·2004
8-other
How to prevent unnecessary coronary interventions: identifying lesions responsible for ischemia in the cath lab.
PMID 12960473·Curr Opin Cardiol·2003
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 601 N CAROLINE ST
BALTIMORE, MD 21287 - Phone
- (410) 955-5933
Quick Facts
- NPI
- 1427074517
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 25
- Publications
- 20
Are you this provider?
Claim Your Profile